Evidence  ||| S:0 E:9 ||| NN
should  ||| S:9 E:16 ||| MD
not  ||| S:16 E:20 ||| RB
be  ||| S:20 E:23 ||| VB
viewed  ||| S:23 E:30 ||| VBN
in  ||| S:30 E:33 ||| IN
isolation  ||| S:33 E:43 ||| NN
After  ||| S:43 E:49 ||| IN
decades  ||| S:49 E:57 ||| NNS
of  ||| S:57 E:60 ||| IN
negative  ||| S:60 E:69 ||| JJ
multicenter ||| S:69 E:80 ||| NN
,  ||| S:80 E:82 ||| ,
randomized ||| S:82 E:92 ||| NN
,  ||| S:92 E:94 ||| ,
placebo-controlled ||| S:94 E:112 ||| NNP
,  ||| S:112 E:114 ||| ,
double-blind  ||| S:114 E:127 ||| JJ
clinical  ||| S:127 E:136 ||| JJ
trials  ||| S:136 E:143 ||| NNS
in  ||| S:143 E:146 ||| IN
patients  ||| S:146 E:155 ||| NNS
with  ||| S:155 E:160 ||| IN
critical  ||| S:160 E:169 ||| JJ
illness ||| S:169 E:176 ||| NN
,  ||| S:176 E:178 ||| ,
the  ||| S:178 E:182 ||| DT
last  ||| S:182 E:187 ||| JJ
decade  ||| S:187 E:194 ||| NN
witnessed  ||| S:194 E:204 ||| VBD
the  ||| S:204 E:208 ||| DT
publication  ||| S:208 E:220 ||| NN
of  ||| S:220 E:223 ||| IN
a  ||| S:223 E:225 ||| DT
series  ||| S:225 E:232 ||| NN
of  ||| S:232 E:235 ||| IN
studies  ||| S:235 E:243 ||| NNS
demonstrating  ||| S:243 E:257 ||| VBG
an  ||| S:257 E:260 ||| DT
improved  ||| S:260 E:269 ||| JJ
outcome  ||| S:269 E:277 ||| NN
for  ||| S:277 E:281 ||| IN
a  ||| S:281 E:283 ||| DT
variety  ||| S:283 E:291 ||| NN
of  ||| S:291 E:294 ||| IN
interventions ||| S:294 E:307 ||| NNS
.  ||| S:307 E:309 ||| .
These  ||| S:309 E:315 ||| DT
positive  ||| S:315 E:324 ||| JJ
studies  ||| S:324 E:332 ||| NNS
and  ||| S:332 E:336 ||| CC
interventions  ||| S:336 E:350 ||| NNS
have  ||| S:350 E:355 ||| VBP
subsequently  ||| S:355 E:368 ||| RB
been  ||| S:368 E:373 ||| VBN
brought  ||| S:373 E:381 ||| VBN
together  ||| S:381 E:390 ||| RP
into  ||| S:390 E:395 ||| IN
bundles  ||| S:395 E:403 ||| NNS
of  ||| S:403 E:406 ||| IN
care ||| S:406 E:410 ||| NN
.  ||| S:410 E:412 ||| .
This  ||| S:412 E:417 ||| DT
rush  ||| S:417 E:422 ||| NN
to  ||| S:422 E:425 ||| TO
change  ||| S:425 E:432 ||| VB
clinicians ||| S:432 E:442 ||| NN
'  ||| S:442 E:444 ||| POS
practice  ||| S:444 E:453 ||| NN
has  ||| S:453 E:457 ||| VBZ
often  ||| S:457 E:463 ||| RB
been  ||| S:463 E:468 ||| VBN
with  ||| S:468 E:473 ||| IN
little  ||| S:473 E:480 ||| JJ
regard  ||| S:480 E:487 ||| NN
for  ||| S:487 E:491 ||| IN
the  ||| S:491 E:495 ||| DT
context  ||| S:495 E:503 ||| NN
in  ||| S:503 E:506 ||| IN
which  ||| S:506 E:512 ||| WDT
the  ||| S:512 E:516 ||| DT
evidence  ||| S:516 E:525 ||| NN
was  ||| S:525 E:529 ||| VBD
generated  ||| S:529 E:539 ||| VBN
and  ||| S:539 E:543 ||| CC
the  ||| S:543 E:547 ||| DT
problems  ||| S:547 E:556 ||| NNS
created  ||| S:556 E:564 ||| VBN
by  ||| S:564 E:567 ||| IN
the  ||| S:567 E:571 ||| DT
difference  ||| S:571 E:582 ||| NN
between  ||| S:582 E:590 ||| IN
efficacy  ||| S:590 E:599 ||| NN
and  ||| S:599 E:603 ||| CC
effectiveness ||| S:603 E:616 ||| NN
.  ||| S:616 E:618 ||| .
This  ||| S:618 E:623 ||| DT
methodology  ||| S:623 E:635 ||| NN
created  ||| S:635 E:643 ||| VBD
a  ||| S:643 E:645 ||| DT
bypass  ||| S:645 E:652 ||| JJ
mechanism  ||| S:652 E:662 ||| NN
through  ||| S:662 E:670 ||| IN
which  ||| S:670 E:676 ||| WDT
implementation  ||| S:676 E:691 ||| VBZ
of  ||| S:691 E:694 ||| IN
a  ||| S:694 E:696 ||| DT
package  ||| S:696 E:704 ||| NN
of  ||| S:704 E:707 ||| IN
interventions  ||| S:707 E:721 ||| NNS
could  ||| S:721 E:727 ||| MD
be  ||| S:727 E:730 ||| VB
fast-tracked  ||| S:730 E:743 ||| JJ
to  ||| S:743 E:746 ||| TO
a  ||| S:746 E:748 ||| DT
much  ||| S:748 E:753 ||| RB
larger  ||| S:753 E:760 ||| JJR
group  ||| S:760 E:766 ||| NN
of  ||| S:766 E:769 ||| IN
critically  ||| S:769 E:780 ||| RB
ill  ||| S:780 E:784 ||| JJ
patients  ||| S:784 E:793 ||| NNS
that  ||| S:793 E:798 ||| WDT
differ  ||| S:798 E:805 ||| VBP
significantly  ||| S:805 E:819 ||| RB
from  ||| S:819 E:824 ||| IN
those  ||| S:824 E:830 ||| DT
in  ||| S:830 E:833 ||| IN
whom  ||| S:833 E:838 ||| WP
the  ||| S:838 E:842 ||| DT
evidence  ||| S:842 E:851 ||| NN
was  ||| S:851 E:855 ||| VBD
generated ||| S:855 E:864 ||| VBN
,  ||| S:864 E:866 ||| ,
without  ||| S:866 E:874 ||| IN
being  ||| S:874 E:880 ||| VBG
validated  ||| S:880 E:890 ||| NN
as  ||| S:890 E:893 ||| IN
a  ||| S:893 E:895 ||| DT
bundle ||| S:895 E:901 ||| NN
.  ||| S:901 E:903 ||| .
The  ||| S:903 E:907 ||| DT
risk  ||| S:907 E:912 ||| NN
of  ||| S:912 E:915 ||| IN
this  ||| S:915 E:920 ||| DT
process  ||| S:920 E:928 ||| NN
is  ||| S:928 E:931 ||| VBZ
that  ||| S:931 E:936 ||| IN
the  ||| S:936 E:940 ||| DT
bundle  ||| S:940 E:947 ||| JJ
tools  ||| S:947 E:953 ||| NNS
will  ||| S:953 E:958 ||| MD
be  ||| S:958 E:961 ||| VB
used  ||| S:961 E:966 ||| VBN
for  ||| S:966 E:970 ||| IN
issues  ||| S:970 E:977 ||| NNS
such  ||| S:977 E:982 ||| JJ
as  ||| S:982 E:985 ||| IN
quality  ||| S:985 E:993 ||| NN
control ||| S:993 E:1000 ||| NN
,  ||| S:1000 E:1002 ||| ,
performance  ||| S:1002 E:1014 ||| NN
evaluation ||| S:1014 E:1024 ||| NN
,  ||| S:1024 E:1026 ||| ,
and  ||| S:1026 E:1030 ||| CC
legal  ||| S:1030 E:1036 ||| JJ
and  ||| S:1036 E:1040 ||| CC
regulatory  ||| S:1040 E:1051 ||| JJ
purposes  ||| S:1051 E:1060 ||| NNS
without  ||| S:1060 E:1068 ||| IN
the  ||| S:1068 E:1072 ||| DT
necessary  ||| S:1072 E:1082 ||| JJ
background  ||| S:1082 E:1093 ||| NN
of  ||| S:1093 E:1096 ||| IN
robust  ||| S:1096 E:1103 ||| JJ
validation  ||| S:1103 E:1114 ||| JJ
studies ||| S:1114 E:1121 ||| NNS
.  ||| S:1121 E:1123 ||| .
This  ||| S:1123 E:1128 ||| DT
has  ||| S:1128 E:1132 ||| VBZ
resulted  ||| S:1132 E:1141 ||| VBN
in  ||| S:1141 E:1144 ||| IN
a  ||| S:1144 E:1146 ||| DT
two-weight ||| S:1146 E:1156 ||| JJ
,  ||| S:1156 E:1158 ||| ,
two-measures  ||| S:1158 E:1171 ||| JJ
situation  ||| S:1171 E:1181 ||| NN
that  ||| S:1181 E:1186 ||| WDT
needs  ||| S:1186 E:1192 ||| VBZ
to  ||| S:1192 E:1195 ||| TO
be  ||| S:1195 E:1198 ||| VB
resolved  ||| S:1198 E:1207 ||| VBN
to  ||| S:1207 E:1210 ||| TO
avoid  ||| S:1210 E:1216 ||| VB
the  ||| S:1216 E:1220 ||| DT
risk  ||| S:1220 E:1225 ||| NN
of  ||| S:1225 E:1228 ||| IN
taking  ||| S:1228 E:1235 ||| VBG
interventions  ||| S:1235 E:1249 ||| NNS
completely  ||| S:1249 E:1260 ||| RB
out  ||| S:1260 E:1264 ||| RB
of  ||| S:1264 E:1267 ||| IN
the  ||| S:1267 E:1271 ||| DT
context  ||| S:1271 E:1279 ||| NN
in  ||| S:1279 E:1282 ||| IN
which  ||| S:1282 E:1288 ||| WDT
the  ||| S:1288 E:1292 ||| DT
positive  ||| S:1292 E:1301 ||| JJ
results  ||| S:1301 E:1309 ||| NNS
were  ||| S:1309 E:1314 ||| VBD
generated  ||| S:1314 E:1324 ||| VBN
and  ||| S:1324 E:1328 ||| CC
putting  ||| S:1328 E:1336 ||| VBG
patients  ||| S:1336 E:1345 ||| NNS
and  ||| S:1345 E:1349 ||| CC
professionals  ||| S:1349 E:1363 ||| NNS
at  ||| S:1363 E:1366 ||| IN
risk  ||| S:1366 E:1371 ||| NN
of  ||| S:1371 E:1374 ||| IN
being  ||| S:1374 E:1380 ||| VBG
harmed  ||| S:1380 E:1387 ||| VBN
by  ||| S:1387 E:1390 ||| IN
the  ||| S:1390 E:1394 ||| DT
package  ||| S:1394 E:1402 ||| NN
of  ||| S:1402 E:1405 ||| IN
interventions ||| S:1405 E:1418 ||| NNS
.  ||| S:1418 E:1420 ||| .
